Global Neural Stem Cells Market - 2025 -2033
Neural Stem Cells Market Size
The global neural stem cells market size reached US$ 4.21 Billion in 2024 and is expected to reach US$ 7.25 Billion by 2033, growing at a CAGR of 6.3% during the forecast period 2025-2033.
Neural Stem Cells Market Overview
The global neural stem cells market is experiencing robust growth, driven by the increasing prevalence of neurological disorders, technological advancements in regenerative medicine, and expanding research applications. Neural stem cells are multipotent cells capable of self-renewal and differentiation into neurons, astrocytes, and oligodendrocytes, making them highly valuable for both therapeutic interventions and in vitro disease modeling. Their unique capacity to regenerate central nervous system (CNS) tissue places NSCs at the forefront of potential treatments for conditions such as Alzheimer’s disease, Parkinson’s disease, spinal cord injury, and multiple sclerosis.
Neural Stem Cells Market Dynamics: Drivers & Restraints
The rising prevalence of neurological disorders is significantly driving the neural stem cells market growth
The rising prevalence of neurological disorders is a major growth driver for the neural stem cells (NSCs) market because these disorders represent a significant unmet medical need with limited effective treatments. NSCs offer promising regenerative and reparative potential for conditions where damaged neurons cannot naturally regenerate. According to the Alzheimer's Association, around 7 million people in the U.S. currently live with Alzheimer’s, projected to nearly double to 13 million by 2050. Existing therapies mostly manage symptoms without halting progression. NSCs have the potential to replace lost neurons and restore cognitive functions, creating strong demand for NSC-based therapies.
A Parkinson’s Foundation-backed study revealed that nearly 90,000 people are diagnosed with Parkinson’s disease in the U.S. each year. This represents a steep 50% increase from the previously estimated rate of 60,000 diagnoses annually. NSC therapies aim to replenish dopaminergic neurons lost in Parkinson’s, providing a disease-modifying approach that current treatments lack. The first autologous NSC trial (Aspen Neuroscience’s ASPIRO) began dosing in 2024, reflecting clinical momentum.
The high cost associated with neural stem cell products is hampering the growth of the market
The process of isolating, culturing, and expanding neural stem cells is complex and requires high levels of precision. Producing high-quality neural stem cells involves expensive bioreactors, specific growth factors, and strict sterile conditions. The need for sophisticated equipment, such as automated stem cell culturing systems, increases costs. For instance, iXCells Biotechnologies’ human neural stem cells (iPSC-derived, ALS) cost $1,078.00, and STEMCELL Technologies’ human IPSC-derived neural progenitor cells cost $995.00.
Neural Stem Cells Market, Segment Analysis
The global neural stem cells market is segmented based on type, application, end-user, and region.
Parkinson's disease from the application segment is expected to hold 22.31% of the market share in 2024 in the neural stem cells market
The National Institute of Health has estimated that the number of people with Parkinson's disease over the age of 50 years is expected to reach around 9 million by 2030, a doubling since 2005, rising to over 12 million by 2040. Parkinson’s disease, a progressive neurodegenerative disorder characterized by the loss of dopamine-producing neurons in the brain, affects millions of people globally. The demand for innovative therapies, particularly stem cell-based treatments, has driven the substantial focus on Parkinson’s disease within the neural stem cells market.
Current Parkinson's disease therapies, such as levodopa, dopamine agonists, only manage symptoms and lose efficacy over time, often leading to dyskinesias and other side effects. Neural stem cells offer the promise of replacing lost dopaminergic neurons or delivering trophic support to slow disease progression capabilities that pharmacologics cannot match.
Neural Stem Cells Market, Geographical Analysis
North America is expected to dominate the global neural stem cells market with a 43.02% share in 2024
North America, especially the United States, is known for the presence of leading biotech companies, such as StemCells Inc., Aspen Neuroscience, Inc., Neuralstem, and Mesoblast, which contribute to innovation and the translation of research into clinical applications. These companies are working on neural stem cell-based therapies for various neurological conditions, including Parkinson's disease and spinal cord injuries. These companies are actively involved in clinical trials which boosting the growth of the market in the region.
For instance, in April 2024, Aspen Neuroscience, Inc. said that the first patient has been dosed in the ASPIRO trial, a Phase 1/2a open-label clinical trial to assess the safety and tolerability of ANPD001, an autologous, dopaminergic neuron cell replacement therapy for participants with moderate to severe Parkinson's disease (PD).
Asia-Pacific is growing at the fastest pace in the neural stem cells market, holding 21.08% of the market share
Countries like China, Japan, and South Korea have implemented favorable policies and regulations to promote stem cell research and therapy. For instance, Japan's Pharmaceuticals and Medical Devices Agency (PMDA) has expedited the approval process for regenerative medicines, while China has established the National Medical Products Administration (NMPA) to streamline regulatory pathways.
The region is witnessing significant advancements in stem cell technologies, including the development of induced pluripotent stem cells (iPSCs) and 3D bioprinting. In 2023, Japan recorded 35 newly launched clinical collaborations for iPSC-driven treatments, reflecting a strong commitment to personalized and off-the-shelf regenerative solutions.
Neural Stem Cells Market Competitive Landscape
Top companies in the neural stem cells market include Athersys, Inc., Thermo Fisher Scientific Inc., STEMCELL Technologies, Merck KGaA, Axol Bioscience Ltd., iXCells Biotechnologies, ALSTEM, Bio-Rad Laboratories, Inc., Alomone Labs, and Lifeline Cell Technology, among others.
The global neural stem cells market report delivers a detailed analysis with 70 key tables, more than 78 visually impactful figures, and 185 pages of expert insights, providing a complete view of the market landscape.
The global neural stem cells market size reached US$ 4.21 Billion in 2024 and is expected to reach US$ 7.25 Billion by 2033, growing at a CAGR of 6.3% during the forecast period 2025-2033.
Neural Stem Cells Market Overview
The global neural stem cells market is experiencing robust growth, driven by the increasing prevalence of neurological disorders, technological advancements in regenerative medicine, and expanding research applications. Neural stem cells are multipotent cells capable of self-renewal and differentiation into neurons, astrocytes, and oligodendrocytes, making them highly valuable for both therapeutic interventions and in vitro disease modeling. Their unique capacity to regenerate central nervous system (CNS) tissue places NSCs at the forefront of potential treatments for conditions such as Alzheimer’s disease, Parkinson’s disease, spinal cord injury, and multiple sclerosis.
Neural Stem Cells Market Dynamics: Drivers & Restraints
The rising prevalence of neurological disorders is significantly driving the neural stem cells market growth
The rising prevalence of neurological disorders is a major growth driver for the neural stem cells (NSCs) market because these disorders represent a significant unmet medical need with limited effective treatments. NSCs offer promising regenerative and reparative potential for conditions where damaged neurons cannot naturally regenerate. According to the Alzheimer's Association, around 7 million people in the U.S. currently live with Alzheimer’s, projected to nearly double to 13 million by 2050. Existing therapies mostly manage symptoms without halting progression. NSCs have the potential to replace lost neurons and restore cognitive functions, creating strong demand for NSC-based therapies.
A Parkinson’s Foundation-backed study revealed that nearly 90,000 people are diagnosed with Parkinson’s disease in the U.S. each year. This represents a steep 50% increase from the previously estimated rate of 60,000 diagnoses annually. NSC therapies aim to replenish dopaminergic neurons lost in Parkinson’s, providing a disease-modifying approach that current treatments lack. The first autologous NSC trial (Aspen Neuroscience’s ASPIRO) began dosing in 2024, reflecting clinical momentum.
The high cost associated with neural stem cell products is hampering the growth of the market
The process of isolating, culturing, and expanding neural stem cells is complex and requires high levels of precision. Producing high-quality neural stem cells involves expensive bioreactors, specific growth factors, and strict sterile conditions. The need for sophisticated equipment, such as automated stem cell culturing systems, increases costs. For instance, iXCells Biotechnologies’ human neural stem cells (iPSC-derived, ALS) cost $1,078.00, and STEMCELL Technologies’ human IPSC-derived neural progenitor cells cost $995.00.
Neural Stem Cells Market, Segment Analysis
The global neural stem cells market is segmented based on type, application, end-user, and region.
Parkinson's disease from the application segment is expected to hold 22.31% of the market share in 2024 in the neural stem cells market
The National Institute of Health has estimated that the number of people with Parkinson's disease over the age of 50 years is expected to reach around 9 million by 2030, a doubling since 2005, rising to over 12 million by 2040. Parkinson’s disease, a progressive neurodegenerative disorder characterized by the loss of dopamine-producing neurons in the brain, affects millions of people globally. The demand for innovative therapies, particularly stem cell-based treatments, has driven the substantial focus on Parkinson’s disease within the neural stem cells market.
Current Parkinson's disease therapies, such as levodopa, dopamine agonists, only manage symptoms and lose efficacy over time, often leading to dyskinesias and other side effects. Neural stem cells offer the promise of replacing lost dopaminergic neurons or delivering trophic support to slow disease progression capabilities that pharmacologics cannot match.
Neural Stem Cells Market, Geographical Analysis
North America is expected to dominate the global neural stem cells market with a 43.02% share in 2024
North America, especially the United States, is known for the presence of leading biotech companies, such as StemCells Inc., Aspen Neuroscience, Inc., Neuralstem, and Mesoblast, which contribute to innovation and the translation of research into clinical applications. These companies are working on neural stem cell-based therapies for various neurological conditions, including Parkinson's disease and spinal cord injuries. These companies are actively involved in clinical trials which boosting the growth of the market in the region.
For instance, in April 2024, Aspen Neuroscience, Inc. said that the first patient has been dosed in the ASPIRO trial, a Phase 1/2a open-label clinical trial to assess the safety and tolerability of ANPD001, an autologous, dopaminergic neuron cell replacement therapy for participants with moderate to severe Parkinson's disease (PD).
Asia-Pacific is growing at the fastest pace in the neural stem cells market, holding 21.08% of the market share
Countries like China, Japan, and South Korea have implemented favorable policies and regulations to promote stem cell research and therapy. For instance, Japan's Pharmaceuticals and Medical Devices Agency (PMDA) has expedited the approval process for regenerative medicines, while China has established the National Medical Products Administration (NMPA) to streamline regulatory pathways.
The region is witnessing significant advancements in stem cell technologies, including the development of induced pluripotent stem cells (iPSCs) and 3D bioprinting. In 2023, Japan recorded 35 newly launched clinical collaborations for iPSC-driven treatments, reflecting a strong commitment to personalized and off-the-shelf regenerative solutions.
Neural Stem Cells Market Competitive Landscape
Top companies in the neural stem cells market include Athersys, Inc., Thermo Fisher Scientific Inc., STEMCELL Technologies, Merck KGaA, Axol Bioscience Ltd., iXCells Biotechnologies, ALSTEM, Bio-Rad Laboratories, Inc., Alomone Labs, and Lifeline Cell Technology, among others.
The global neural stem cells market report delivers a detailed analysis with 70 key tables, more than 78 visually impactful figures, and 185 pages of expert insights, providing a complete view of the market landscape.
1. MARKET INTRODUCTION AND SCOPE
1.1. Objectives of the Report
1.2. Report Coverage & Definitions
1.3. Report Scope
2. EXECUTIVE INSIGHTS AND KEY TAKEAWAYS
3. MARKET HIGHLIGHTS AND STRATEGIC TAKEAWAYS
3.1. Key Trends and Future Projections
3.2. Snippet by Type
3.3. Snippet by Application
3.4. Snippet by End-User
3.5. Snippet by Region
4. DYNAMICS
4.1. Impacting Factors
4.1.1. Drivers
4.1.1.1. Rising Prevalence of Neurological Disorders
4.1.1.2. Advancements in Stem Cell and Neuroscience Research
4.1.1.3. Growing Demand for Personalized/Autologous Neural Therapies
4.1.2. Restraints
4.1.2.1. High Cost Associated with Neural Stem Cell Products
4.1.2.2. Complexities in Cell Differentiation and Reprogramming
4.1.2.3. Safety and Efficacy Uncertainties with Limited Clinical Data
4.1.3. Opportunity
4.1.3.1. Personalized Regenerative Neurology for Neurodegenerative Diseases
4.1.3.2. Integration with Advanced Biomaterials and 3D Biofabrication
4.1.4. Impact Analysis
5. STRATEGIC INSIGHTS AND INDUSTRY OUTLOOK
5.1. Market Leaders and Pioneers
5.1.1. Emerging Pioneers and Prominent Players
5.1.2. Established Leaders with the Largest Marketing Brand
5.1.3. Market Leaders with Established Products
5.2. Latest Developments and Breakthroughs
5.3. Regulatory and Reimbursement Landscape
5.3.1. North America
5.3.2. Europe
5.3.3. Asia Pacific
5.3.4. South America
5.3.5. Middle East & Africa
5.4. Porter’s Five Forces Analysis
5.5. Supply Chain Analysis
5.6. Patent Analysis
5.7. SWOT Analysis
5.8. Unmet Needs and Gaps
5.9. Recommended Strategies for Market Entry and Expansion
5.10. Pricing Analysis and Price Dynamics
6. NEURAL STEM CELLS MARKET, BY TYPE
6.1. Introduction
6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
6.1.2. Market Attractiveness Index, By Type
6.2. Human Neural Stem Cells*
6.2.1. Introduction
6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
6.3. Animal-Derived Neural Stem Cells
6.4. Embryonic Stem Cells
6.5. Induced Pluripotent Stem Cells
7. NEURAL STEM CELLS MARKET, BY APPLICATION
7.1. Introduction
7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
7.1.2. Market Attractiveness Index, By Application
7.2. Alzheimer's Disease*
7.2.1. Introduction
7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Parkinson's Disease
7.4. Multiple Sclerosis
7.5. Traumatic Brain Injury
7.6. Schizophrenia
7.7. Epilepsy
7.8. Others
8. NEURAL STEM CELLS MARKET, BY END-USER
8.1. Introduction
8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
8.1.2. Market Attractiveness Index, By End-User
8.2. Hospitals and Clinics*
8.2.1. Introduction
8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Research Institutions and Academic Centers
8.4. Pharmaceutical and Biotech Companies
8.5. Others
9. NEURAL STEM CELLS MARKET, BY REGIONAL MARKET ANALYSIS AND GROWTH OPPORTUNITIES
9.1. Introduction
9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
9.1.1.1. Market Attractiveness Index, By Region
9.1.2. North America
9.1.2.1. Introduction
9.1.2.2. Key Region-Specific Dynamics
9.1.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
9.1.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
9.1.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
9.1.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
9.1.2.6.1. U.S.
9.1.2.6.2. Canada
9.1.2.6.3. Mexico
9.1.3. Europe
9.1.3.1. Introduction
9.1.3.2. Key Region-Specific Dynamics
9.1.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
9.1.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
9.1.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
9.1.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
9.1.3.6.1. Germany
9.1.3.6.2. UK
9.1.3.6.3. France
9.1.3.6.4. Spain
9.1.3.6.5. Italy
9.1.3.6.6. Rest of Europe
9.1.4. Asia-Pacific
9.1.4.1. Introduction
9.1.4.2. Key Region-Specific Dynamics
9.1.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
9.1.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
9.1.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
9.1.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
9.1.4.6.1. China
9.1.4.6.2. India
9.1.4.6.3. Japan
9.1.4.6.4. South Korea
9.1.4.6.5. Rest of Asia-Pacific
9.1.5. South America
9.1.5.1. Introduction
9.1.5.2. Key Region-Specific Dynamics
9.1.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
9.1.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
9.1.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
9.1.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
9.1.5.6.1. Brazil
9.1.5.6.2. Argentina
9.1.5.6.3. Rest of South America
9.1.6. Middle East and Africa
9.1.6.1. Introduction
9.1.6.2. Key Region-Specific Dynamics
9.1.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
9.1.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
9.1.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
10. COMPETITIVE LANDSCAPE AND MARKET POSITIONING
11. COMPETITIVE OVERVIEW AND KEY MARKET PLAYERS
11.1. Market Share Analysis and Positioning Matrix
11.2. Strategic Partnerships, Mergers & Acquisitions
11.3. Key Developments in Product Portfolios and Innovations
11.4. Company Benchmarking
12. COMPANY PROFILES
12.1. Athersys, Inc.*
12.1.1. Company Overview
12.1.2. Product Portfolio
12.1.2.1. Product Description
12.1.2.2. Product Key Performance Indicators (KPIs)
13. FINANCIAL OVERVIEW
13.1. Company Revenue
13.1.1. Geographical Revenue Shares
13.1.1.1. Revenue Forecasts
13.1.2. Key Developments
13.1.2.1. Mergers & Acquisitions
13.1.2.2. Key Product Development Activities
13.1.2.3. Regulatory Approvals, etc.
13.1.3. SWOT Analysis
13.2. Thermo Fisher Scientific Inc.
13.3. STEMCELL Technologies
13.4. Merck KGaA
13.5. Axol Bioscience Ltd.
13.6. iXCells Biotechnologies
13.7. ALSTEM
13.8. Bio-Rad Laboratories, Inc.
13.9. Alomone Labs
13.10. Lifeline Cell Technology ( LIST NOT EXHAUSTIVE)
14. ASSUMPTIONS AND RESEARCH METHODOLOGY
14.1. Data Collection Methods
14.2. Data Triangulation
14.3. Forecasting Techniques
14.4. Data Verification and Validation
15. APPENDIX
15.1. About Us and Services
15.2. Contact Us
1.1. Objectives of the Report
1.2. Report Coverage & Definitions
1.3. Report Scope
2. EXECUTIVE INSIGHTS AND KEY TAKEAWAYS
3. MARKET HIGHLIGHTS AND STRATEGIC TAKEAWAYS
3.1. Key Trends and Future Projections
3.2. Snippet by Type
3.3. Snippet by Application
3.4. Snippet by End-User
3.5. Snippet by Region
4. DYNAMICS
4.1. Impacting Factors
4.1.1. Drivers
4.1.1.1. Rising Prevalence of Neurological Disorders
4.1.1.2. Advancements in Stem Cell and Neuroscience Research
4.1.1.3. Growing Demand for Personalized/Autologous Neural Therapies
4.1.2. Restraints
4.1.2.1. High Cost Associated with Neural Stem Cell Products
4.1.2.2. Complexities in Cell Differentiation and Reprogramming
4.1.2.3. Safety and Efficacy Uncertainties with Limited Clinical Data
4.1.3. Opportunity
4.1.3.1. Personalized Regenerative Neurology for Neurodegenerative Diseases
4.1.3.2. Integration with Advanced Biomaterials and 3D Biofabrication
4.1.4. Impact Analysis
5. STRATEGIC INSIGHTS AND INDUSTRY OUTLOOK
5.1. Market Leaders and Pioneers
5.1.1. Emerging Pioneers and Prominent Players
5.1.2. Established Leaders with the Largest Marketing Brand
5.1.3. Market Leaders with Established Products
5.2. Latest Developments and Breakthroughs
5.3. Regulatory and Reimbursement Landscape
5.3.1. North America
5.3.2. Europe
5.3.3. Asia Pacific
5.3.4. South America
5.3.5. Middle East & Africa
5.4. Porter’s Five Forces Analysis
5.5. Supply Chain Analysis
5.6. Patent Analysis
5.7. SWOT Analysis
5.8. Unmet Needs and Gaps
5.9. Recommended Strategies for Market Entry and Expansion
5.10. Pricing Analysis and Price Dynamics
6. NEURAL STEM CELLS MARKET, BY TYPE
6.1. Introduction
6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
6.1.2. Market Attractiveness Index, By Type
6.2. Human Neural Stem Cells*
6.2.1. Introduction
6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
6.3. Animal-Derived Neural Stem Cells
6.4. Embryonic Stem Cells
6.5. Induced Pluripotent Stem Cells
7. NEURAL STEM CELLS MARKET, BY APPLICATION
7.1. Introduction
7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
7.1.2. Market Attractiveness Index, By Application
7.2. Alzheimer's Disease*
7.2.1. Introduction
7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Parkinson's Disease
7.4. Multiple Sclerosis
7.5. Traumatic Brain Injury
7.6. Schizophrenia
7.7. Epilepsy
7.8. Others
8. NEURAL STEM CELLS MARKET, BY END-USER
8.1. Introduction
8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
8.1.2. Market Attractiveness Index, By End-User
8.2. Hospitals and Clinics*
8.2.1. Introduction
8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Research Institutions and Academic Centers
8.4. Pharmaceutical and Biotech Companies
8.5. Others
9. NEURAL STEM CELLS MARKET, BY REGIONAL MARKET ANALYSIS AND GROWTH OPPORTUNITIES
9.1. Introduction
9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
9.1.1.1. Market Attractiveness Index, By Region
9.1.2. North America
9.1.2.1. Introduction
9.1.2.2. Key Region-Specific Dynamics
9.1.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
9.1.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
9.1.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
9.1.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
9.1.2.6.1. U.S.
9.1.2.6.2. Canada
9.1.2.6.3. Mexico
9.1.3. Europe
9.1.3.1. Introduction
9.1.3.2. Key Region-Specific Dynamics
9.1.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
9.1.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
9.1.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
9.1.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
9.1.3.6.1. Germany
9.1.3.6.2. UK
9.1.3.6.3. France
9.1.3.6.4. Spain
9.1.3.6.5. Italy
9.1.3.6.6. Rest of Europe
9.1.4. Asia-Pacific
9.1.4.1. Introduction
9.1.4.2. Key Region-Specific Dynamics
9.1.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
9.1.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
9.1.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
9.1.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
9.1.4.6.1. China
9.1.4.6.2. India
9.1.4.6.3. Japan
9.1.4.6.4. South Korea
9.1.4.6.5. Rest of Asia-Pacific
9.1.5. South America
9.1.5.1. Introduction
9.1.5.2. Key Region-Specific Dynamics
9.1.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
9.1.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
9.1.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
9.1.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
9.1.5.6.1. Brazil
9.1.5.6.2. Argentina
9.1.5.6.3. Rest of South America
9.1.6. Middle East and Africa
9.1.6.1. Introduction
9.1.6.2. Key Region-Specific Dynamics
9.1.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
9.1.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
9.1.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
10. COMPETITIVE LANDSCAPE AND MARKET POSITIONING
11. COMPETITIVE OVERVIEW AND KEY MARKET PLAYERS
11.1. Market Share Analysis and Positioning Matrix
11.2. Strategic Partnerships, Mergers & Acquisitions
11.3. Key Developments in Product Portfolios and Innovations
11.4. Company Benchmarking
12. COMPANY PROFILES
12.1. Athersys, Inc.*
12.1.1. Company Overview
12.1.2. Product Portfolio
12.1.2.1. Product Description
12.1.2.2. Product Key Performance Indicators (KPIs)
13. FINANCIAL OVERVIEW
13.1. Company Revenue
13.1.1. Geographical Revenue Shares
13.1.1.1. Revenue Forecasts
13.1.2. Key Developments
13.1.2.1. Mergers & Acquisitions
13.1.2.2. Key Product Development Activities
13.1.2.3. Regulatory Approvals, etc.
13.1.3. SWOT Analysis
13.2. Thermo Fisher Scientific Inc.
13.3. STEMCELL Technologies
13.4. Merck KGaA
13.5. Axol Bioscience Ltd.
13.6. iXCells Biotechnologies
13.7. ALSTEM
13.8. Bio-Rad Laboratories, Inc.
13.9. Alomone Labs
13.10. Lifeline Cell Technology ( LIST NOT EXHAUSTIVE)
14. ASSUMPTIONS AND RESEARCH METHODOLOGY
14.1. Data Collection Methods
14.2. Data Triangulation
14.3. Forecasting Techniques
14.4. Data Verification and Validation
15. APPENDIX
15.1. About Us and Services
15.2. Contact Us
LIST OF TABLES
Table 1 Global Neural Stem Cells Market Value, By Type, 2023, 2027 & 2031 (US$ Million)
Table 2 Global Neural Stem Cells Market Value, By Application, 2023, 2027 & 2031 (US$ Million)
Table 3 Global Neural Stem Cells Market Value, By End-User, 2023, 2027 & 2031 (US$ Million)
Table 4 Global Neural Stem Cells Market Value, By Region, 2023, 2027 & 2031 (US$ Million)
Table 5 Global Neural Stem Cells Market Value, By Type, 2023, 2027 & 2031 (US$ Million)
Table 6 Global Neural Stem Cells Market Value, By Type, 2022-2031 (US$ Million)
Table 7 Global Neural Stem Cells Market Value, By Application, 2023, 2027 & 2031 (US$ Million)
Table 8 Global Neural Stem Cells Market Value, By Application, 2022-2031 (US$ Million)
Table 9 Global Neural Stem Cells Market Value, By End-User, 2023, 2027 & 2031 (US$ Million)
Table 10 Global Neural Stem Cells Market Value, By End-User, 2022-2031 (US$ Million)
Table 11 Global Neural Stem Cells Market Value, By Region, 2023, 2027 & 2031 (US$ Million)
Table 12 Global Neural Stem Cells Market Value, By Region, 2022-2031 (US$ Million)
Table 13 North America Neural Stem Cells Market Value, By Type, 2022-2031 (US$ Million)
Table 14 North America Neural Stem Cells Market Value, By Application, 2022-2031 (US$ Million)
Table 15 North America Neural Stem Cells Market Value, By End-User, 2022-2031 (US$ Million)
Table 16 North America Neural Stem Cells Market Value, By Country, 2022-2031 (US$ Million)
Table 17 Asia-Pacific Neural Stem Cells Market Value, By Type, 2022-2031 (US$ Million)
Table 18 Asia-Pacific Neural Stem Cells Market Value, By Application, 2022-2031 (US$ Million)
Table 19 Asia-Pacific Neural Stem Cells Market Value, By End-User, 2022-2031 (US$ Million)
Table 20 Asia-Pacific Neural Stem Cells Market Value, By Country, 2022-2031 (US$ Million)
Table 21 Europe Neural Stem Cells Market Value, By Type, 2022-2031 (US$ Million)
Table 22 Europe Neural Stem Cells Market Value, By Application, 2022-2031 (US$ Million)
Table 23 Europe Neural Stem Cells Market Value, By End-User, 2022-2031 (US$ Million)
Table 24 Europe Neural Stem Cells Market Value, By Country, 2022-2031 (US$ Million)
Table 25 South America Neural Stem Cells Market Value, By Type, 2022-2031 (US$ Million)
Table 26 South America Neural Stem Cells Market Value, By Application, 2022-2031 (US$ Million)
Table 27 South America Neural Stem Cells Market Value, By End-User, 2022-2031 (US$ Million)
Table 28 South America Neural Stem Cells Market Value, By Country, 2022-2031 (US$ Million)
Table 29 Middle East and Africa Neural Stem Cells Market Value, By Type, 2022-2031 (US$ Million)
Table 30 Middle East and Africa Neural Stem Cells Market Value, By Application, 2022-2031 (US$ Million)
Table 31 Middle East and Africa Neural Stem Cells Market Value, By End-User, 2022-2031 (US$ Million)
Table 32 Middle East and Africa Neural Stem Cells Market Value, By Country, 2022-2031 (US$ Million)
Table 33 Athersys, Inc.: Overview
Table 34 Athersys, Inc.: Product Portfolio
Table 35 Athersys, Inc.: Key Developments
Table 36 Thermo Fisher Scientific Inc.: Overview
Table 37 Thermo Fisher Scientific Inc.: Product Portfolio
Table 38 Thermo Fisher Scientific Inc.: Key Developments
Table 39 STEMCELL Technologies: Overview
Table 40 STEMCELL Technologies: Product Portfolio
Table 41 STEMCELL Technologies: Key Developments
Table 42 Merck KGaA: Overview
Table 43 Merck KGaA: Product Portfolio
Table 44 Merck KGaA: Key Developments
Table 45 Axol Bioscience Ltd.: Overview
Table 46 Axol Bioscience Ltd.: Product Portfolio
Table 47 Axol Bioscience Ltd.: Key Developments
Table 48 iXCells Biotechnologies: Overview
Table 49 iXCells Biotechnologies: Product Portfolio
Table 50 iXCells Biotechnologies: Key Developments
Table 51 ALSTEM: Overview
Table 52 ALSTEM: Product Portfolio
Table 53 ALSTEM: Key Developments
Table 54 Bio-Rad Laboratories, Inc.: Overview
Table 55 Bio-Rad Laboratories, Inc.: Product Portfolio
Table 56 Bio-Rad Laboratories, Inc.: Key Developments
Table 57 Alomone Labs: Overview
Table 58 Alomone Labs: Product Portfolio
Table 59 Alomone Labs: Key Developments
Table 60 Lifeline Cell Technology: Overview
Table 61 Lifeline Cell Technology: Product Portfolio
Table 62 Lifeline Cell Technology: Key Developments
Table 1 Global Neural Stem Cells Market Value, By Type, 2023, 2027 & 2031 (US$ Million)
Table 2 Global Neural Stem Cells Market Value, By Application, 2023, 2027 & 2031 (US$ Million)
Table 3 Global Neural Stem Cells Market Value, By End-User, 2023, 2027 & 2031 (US$ Million)
Table 4 Global Neural Stem Cells Market Value, By Region, 2023, 2027 & 2031 (US$ Million)
Table 5 Global Neural Stem Cells Market Value, By Type, 2023, 2027 & 2031 (US$ Million)
Table 6 Global Neural Stem Cells Market Value, By Type, 2022-2031 (US$ Million)
Table 7 Global Neural Stem Cells Market Value, By Application, 2023, 2027 & 2031 (US$ Million)
Table 8 Global Neural Stem Cells Market Value, By Application, 2022-2031 (US$ Million)
Table 9 Global Neural Stem Cells Market Value, By End-User, 2023, 2027 & 2031 (US$ Million)
Table 10 Global Neural Stem Cells Market Value, By End-User, 2022-2031 (US$ Million)
Table 11 Global Neural Stem Cells Market Value, By Region, 2023, 2027 & 2031 (US$ Million)
Table 12 Global Neural Stem Cells Market Value, By Region, 2022-2031 (US$ Million)
Table 13 North America Neural Stem Cells Market Value, By Type, 2022-2031 (US$ Million)
Table 14 North America Neural Stem Cells Market Value, By Application, 2022-2031 (US$ Million)
Table 15 North America Neural Stem Cells Market Value, By End-User, 2022-2031 (US$ Million)
Table 16 North America Neural Stem Cells Market Value, By Country, 2022-2031 (US$ Million)
Table 17 Asia-Pacific Neural Stem Cells Market Value, By Type, 2022-2031 (US$ Million)
Table 18 Asia-Pacific Neural Stem Cells Market Value, By Application, 2022-2031 (US$ Million)
Table 19 Asia-Pacific Neural Stem Cells Market Value, By End-User, 2022-2031 (US$ Million)
Table 20 Asia-Pacific Neural Stem Cells Market Value, By Country, 2022-2031 (US$ Million)
Table 21 Europe Neural Stem Cells Market Value, By Type, 2022-2031 (US$ Million)
Table 22 Europe Neural Stem Cells Market Value, By Application, 2022-2031 (US$ Million)
Table 23 Europe Neural Stem Cells Market Value, By End-User, 2022-2031 (US$ Million)
Table 24 Europe Neural Stem Cells Market Value, By Country, 2022-2031 (US$ Million)
Table 25 South America Neural Stem Cells Market Value, By Type, 2022-2031 (US$ Million)
Table 26 South America Neural Stem Cells Market Value, By Application, 2022-2031 (US$ Million)
Table 27 South America Neural Stem Cells Market Value, By End-User, 2022-2031 (US$ Million)
Table 28 South America Neural Stem Cells Market Value, By Country, 2022-2031 (US$ Million)
Table 29 Middle East and Africa Neural Stem Cells Market Value, By Type, 2022-2031 (US$ Million)
Table 30 Middle East and Africa Neural Stem Cells Market Value, By Application, 2022-2031 (US$ Million)
Table 31 Middle East and Africa Neural Stem Cells Market Value, By End-User, 2022-2031 (US$ Million)
Table 32 Middle East and Africa Neural Stem Cells Market Value, By Country, 2022-2031 (US$ Million)
Table 33 Athersys, Inc.: Overview
Table 34 Athersys, Inc.: Product Portfolio
Table 35 Athersys, Inc.: Key Developments
Table 36 Thermo Fisher Scientific Inc.: Overview
Table 37 Thermo Fisher Scientific Inc.: Product Portfolio
Table 38 Thermo Fisher Scientific Inc.: Key Developments
Table 39 STEMCELL Technologies: Overview
Table 40 STEMCELL Technologies: Product Portfolio
Table 41 STEMCELL Technologies: Key Developments
Table 42 Merck KGaA: Overview
Table 43 Merck KGaA: Product Portfolio
Table 44 Merck KGaA: Key Developments
Table 45 Axol Bioscience Ltd.: Overview
Table 46 Axol Bioscience Ltd.: Product Portfolio
Table 47 Axol Bioscience Ltd.: Key Developments
Table 48 iXCells Biotechnologies: Overview
Table 49 iXCells Biotechnologies: Product Portfolio
Table 50 iXCells Biotechnologies: Key Developments
Table 51 ALSTEM: Overview
Table 52 ALSTEM: Product Portfolio
Table 53 ALSTEM: Key Developments
Table 54 Bio-Rad Laboratories, Inc.: Overview
Table 55 Bio-Rad Laboratories, Inc.: Product Portfolio
Table 56 Bio-Rad Laboratories, Inc.: Key Developments
Table 57 Alomone Labs: Overview
Table 58 Alomone Labs: Product Portfolio
Table 59 Alomone Labs: Key Developments
Table 60 Lifeline Cell Technology: Overview
Table 61 Lifeline Cell Technology: Product Portfolio
Table 62 Lifeline Cell Technology: Key Developments
LIST OF FIGURES
Figure 1 Global Neural Stem Cells Market Value, 2022-2031 (US$ Million)
Figure 2 Global Neural Stem Cells Market Share, By Type, 2023 & 2031 (%)
Figure 3 Global Neural Stem Cells Market Share, By Application, 2023 & 2031 (%)
Figure 4 Global Neural Stem Cells Market Share, By End-User, 2023 & 2031 (%)
Figure 5 Global Neural Stem Cells Market Share, By Region, 2023 & 2031 (%)
Figure 6 Global Neural Stem Cells Market Y-o-Y Growth, By Type, 2023-2031 (%)
Figure 7 Human Neural Stem Cells Neural Stem Cells Market Value, 2022-2031 (US$ Million)
Figure 8 Animal Derived Neural Stem Cells Neural Stem Cells Market Value, 2022-2031 (US$ Million)
Figure 9 Embryonic Stem Cells Neural Stem Cells Market Value, 2022-2031 (US$ Million)
Figure 10 Induced Pluripotent Stem Cells Neural Stem Cells Market Value, 2022-2031 (US$ Million)
Figure 11 Global Neural Stem Cells Market Y-o-Y Growth, By Application, 2023-2031 (%)
Figure 12 Alzheimer's Disease Application in Global Neural Stem Cells Market Value, 2022-2031 (US$ Million)
Figure 13 Parkinson's Disease Application in Global Neural Stem Cells Market Value, 2022-2031 (US$ Million)
Figure 14 Multiple Sclerosis Application in Global Neural Stem Cells Market Value, 2022-2031 (US$ Million)
Figure 15 Traumatic Brain Injury Application in Global Neural Stem Cells Market Value, 2022-2031 (US$ Million)
Figure 16 Schizophrenia Application in Global Neural Stem Cells Market Value, 2022-2031 (US$ Million)
Figure 17 Epilepsy Application in Global Neural Stem Cells Market Value, 2022-2031 (US$ Million)
Figure 18 Others Application in Global Neural Stem Cells Market Value, 2022-2031 (US$ Million)
Figure 19 Global Neural Stem Cells Market Y-o-Y Growth, By End-User, 2023-2031 (%)
Figure 20 Hospitals and Clinics End-User in Global Neural Stem Cells Market Value, 2022-2031 (US$ Million)
Figure 21 Research Institutions and Academic Centers End-User in Global Neural Stem Cells Market Value, 2022-2031 (US$ Million)
Figure 22 Pharmaceutical and Biotech Companies End-User in Global Neural Stem Cells Market Value, 2022-2031 (US$ Million)
Figure 23 Others End-User in Global Neural Stem Cells Market Value, 2022-2031 (US$ Million)
Figure 24 Global Neural Stem Cells Market Y-o-Y Growth, By Region, 2023-2031 (%)
Figure 25 North America Neural Stem Cells Market Value, 2022-2031 (US$ Million)
Figure 26 North America Neural Stem Cells Market Share, By Type, 2023 & 2031 (%)
Figure 27 North America Neural Stem Cells Market Share, By Application, 2023 & 2031 (%)
Figure 28 North America Neural Stem Cells Market Share, By End-User, 2023 & 2031 (%)
Figure 29 North America Neural Stem Cells Market Share, By Country, 2023 & 2031 (%)
Figure 30 Asia-Pacific Neural Stem Cells Market Value, 2022-2031 (US$ Million)
Figure 31 Asia-Pacific Neural Stem Cells Market Share, By Type, 2023 & 2031 (%)
Figure 32 Asia-Pacific Neural Stem Cells Market Share, By Application, 2023 & 2031 (%)
Figure 33 Asia-Pacific Neural Stem Cells Market Share, By End-User, 2023 & 2031 (%)
Figure 34 Asia-Pacific Neural Stem Cells Market Share, By Country, 2023 & 2031 (%)
Figure 35 Europe Neural Stem Cells Market Value, 2022-2031 (US$ Million)
Figure 36 Europe Neural Stem Cells Market Share, By Type, 2023 & 2031 (%)
Figure 37 Europe Neural Stem Cells Market Share, By Application, 2023 & 2031 (%)
Figure 38 Europe Neural Stem Cells Market Share, By End-User, 2023 & 2031 (%)
Figure 39 Europe Neural Stem Cells Market Share, By Country, 2023 & 2031 (%)
Figure 40 South America Neural Stem Cells Market Value, 2022-2031 (US$ Million)
Figure 41 South America Neural Stem Cells Market Share, By Type, 2023 & 2031 (%)
Figure 42 South America Neural Stem Cells Market Share, By Application, 2023 & 2031 (%)
Figure 43 South America Neural Stem Cells Market Share, By End-User, 2023 & 2031 (%)
Figure 44 South America Neural Stem Cells Market Share, By Country, 2023 & 2031 (%)
Figure 45 Middle East and Africa Neural Stem Cells Market Value, 2022-2031 (US$ Million)
Figure 46 Middle East and Africa Neural Stem Cells Market Share, By Type, 2023 & 2031 (%)
Figure 47 Middle East and Africa Neural Stem Cells Market Share, By Application, 2023 & 2031 (%)
Figure 48 Middle East and Africa Neural Stem Cells Market Share, By End-User, 2023 & 2031 (%)
Figure 49 Athersys, Inc.: Financials
Figure 50 Thermo Fisher Scientific Inc.: Financials
Figure 51 STEMCELL Technologies: Financials
Figure 52 Merck KGaA: Financials
Figure 53 Axol Bioscience Ltd.: Financials
Figure 54 iXCells Biotechnologies: Financials
Figure 55 ALSTEM: Financials
Figure 56 Bio-Rad Laboratories, Inc.: Financials
Figure 57 Alomone Labs: Financials
Figure 58 Lifeline Cell Technology: Financials
Figure 1 Global Neural Stem Cells Market Value, 2022-2031 (US$ Million)
Figure 2 Global Neural Stem Cells Market Share, By Type, 2023 & 2031 (%)
Figure 3 Global Neural Stem Cells Market Share, By Application, 2023 & 2031 (%)
Figure 4 Global Neural Stem Cells Market Share, By End-User, 2023 & 2031 (%)
Figure 5 Global Neural Stem Cells Market Share, By Region, 2023 & 2031 (%)
Figure 6 Global Neural Stem Cells Market Y-o-Y Growth, By Type, 2023-2031 (%)
Figure 7 Human Neural Stem Cells Neural Stem Cells Market Value, 2022-2031 (US$ Million)
Figure 8 Animal Derived Neural Stem Cells Neural Stem Cells Market Value, 2022-2031 (US$ Million)
Figure 9 Embryonic Stem Cells Neural Stem Cells Market Value, 2022-2031 (US$ Million)
Figure 10 Induced Pluripotent Stem Cells Neural Stem Cells Market Value, 2022-2031 (US$ Million)
Figure 11 Global Neural Stem Cells Market Y-o-Y Growth, By Application, 2023-2031 (%)
Figure 12 Alzheimer's Disease Application in Global Neural Stem Cells Market Value, 2022-2031 (US$ Million)
Figure 13 Parkinson's Disease Application in Global Neural Stem Cells Market Value, 2022-2031 (US$ Million)
Figure 14 Multiple Sclerosis Application in Global Neural Stem Cells Market Value, 2022-2031 (US$ Million)
Figure 15 Traumatic Brain Injury Application in Global Neural Stem Cells Market Value, 2022-2031 (US$ Million)
Figure 16 Schizophrenia Application in Global Neural Stem Cells Market Value, 2022-2031 (US$ Million)
Figure 17 Epilepsy Application in Global Neural Stem Cells Market Value, 2022-2031 (US$ Million)
Figure 18 Others Application in Global Neural Stem Cells Market Value, 2022-2031 (US$ Million)
Figure 19 Global Neural Stem Cells Market Y-o-Y Growth, By End-User, 2023-2031 (%)
Figure 20 Hospitals and Clinics End-User in Global Neural Stem Cells Market Value, 2022-2031 (US$ Million)
Figure 21 Research Institutions and Academic Centers End-User in Global Neural Stem Cells Market Value, 2022-2031 (US$ Million)
Figure 22 Pharmaceutical and Biotech Companies End-User in Global Neural Stem Cells Market Value, 2022-2031 (US$ Million)
Figure 23 Others End-User in Global Neural Stem Cells Market Value, 2022-2031 (US$ Million)
Figure 24 Global Neural Stem Cells Market Y-o-Y Growth, By Region, 2023-2031 (%)
Figure 25 North America Neural Stem Cells Market Value, 2022-2031 (US$ Million)
Figure 26 North America Neural Stem Cells Market Share, By Type, 2023 & 2031 (%)
Figure 27 North America Neural Stem Cells Market Share, By Application, 2023 & 2031 (%)
Figure 28 North America Neural Stem Cells Market Share, By End-User, 2023 & 2031 (%)
Figure 29 North America Neural Stem Cells Market Share, By Country, 2023 & 2031 (%)
Figure 30 Asia-Pacific Neural Stem Cells Market Value, 2022-2031 (US$ Million)
Figure 31 Asia-Pacific Neural Stem Cells Market Share, By Type, 2023 & 2031 (%)
Figure 32 Asia-Pacific Neural Stem Cells Market Share, By Application, 2023 & 2031 (%)
Figure 33 Asia-Pacific Neural Stem Cells Market Share, By End-User, 2023 & 2031 (%)
Figure 34 Asia-Pacific Neural Stem Cells Market Share, By Country, 2023 & 2031 (%)
Figure 35 Europe Neural Stem Cells Market Value, 2022-2031 (US$ Million)
Figure 36 Europe Neural Stem Cells Market Share, By Type, 2023 & 2031 (%)
Figure 37 Europe Neural Stem Cells Market Share, By Application, 2023 & 2031 (%)
Figure 38 Europe Neural Stem Cells Market Share, By End-User, 2023 & 2031 (%)
Figure 39 Europe Neural Stem Cells Market Share, By Country, 2023 & 2031 (%)
Figure 40 South America Neural Stem Cells Market Value, 2022-2031 (US$ Million)
Figure 41 South America Neural Stem Cells Market Share, By Type, 2023 & 2031 (%)
Figure 42 South America Neural Stem Cells Market Share, By Application, 2023 & 2031 (%)
Figure 43 South America Neural Stem Cells Market Share, By End-User, 2023 & 2031 (%)
Figure 44 South America Neural Stem Cells Market Share, By Country, 2023 & 2031 (%)
Figure 45 Middle East and Africa Neural Stem Cells Market Value, 2022-2031 (US$ Million)
Figure 46 Middle East and Africa Neural Stem Cells Market Share, By Type, 2023 & 2031 (%)
Figure 47 Middle East and Africa Neural Stem Cells Market Share, By Application, 2023 & 2031 (%)
Figure 48 Middle East and Africa Neural Stem Cells Market Share, By End-User, 2023 & 2031 (%)
Figure 49 Athersys, Inc.: Financials
Figure 50 Thermo Fisher Scientific Inc.: Financials
Figure 51 STEMCELL Technologies: Financials
Figure 52 Merck KGaA: Financials
Figure 53 Axol Bioscience Ltd.: Financials
Figure 54 iXCells Biotechnologies: Financials
Figure 55 ALSTEM: Financials
Figure 56 Bio-Rad Laboratories, Inc.: Financials
Figure 57 Alomone Labs: Financials
Figure 58 Lifeline Cell Technology: Financials
